China Primary Hyperoxaluria (PH) Therapeutics Market Analysis

China Primary Hyperoxaluria (PH) Therapeutics Market Analysis


$ 3999

The China Primary Hyperoxaluria (PH) Therapeutics Market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 6.3% from 2022 to 2030 and will reach $XX B in 2030. One of the main reasons propelling the growth of this market is, advancement of medication. The market is segmented by diagnostic method, by treatment, by type. Some key players in this market are Arbor Pharmaceuticals, Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, OxThera, Retrophin Pharma, Pharming Group among others.

ID: IN10CNPH507 CATEGORY: Pharmaceuticals GEOGRAPHY: China AUTHOR: Nandini Shah

Buy Now

China Primary Hyperoxaluria (PH) Therapeutics Market Executive Summary

The China Primary Hyperoxaluria (PH) Therapeutics market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 6.3% from 2022 to 2030 and will reach $XX B in 2030. Due to the accumulation of oxalate in the body as a result of the rare hereditary condition primary hyperoxaluria, kidney damage, kidney stones, and other severe health issues can occur. Although the primary hyperoxaluria market in China is now quite small, it is anticipated to expand over the next few years as a result of rising awareness and easier access to healthcare.

The vast population of China, which includes a sizable number of people with rare genetic illnesses, is one of the key factors influencing growth in the primary hyperoxaluria market. Also, the Chinese government has adopted healthcare reforms in recent years that are intended to improve funding for R&D and extend access to healthcare services. RNA interference (RNAi) therapies and small molecule medications are among the prospective treatments for primary hyperoxaluria being developed by a number of pharmaceutical companies. Although these businesses in China confront considerable difficulties with reimbursement and regulation, current reforms and legislation might offer chances for market expansion.

Market Dynamics

Market Growth Drivers

The incidence of primary hyperoxaluria is increasing in China due to changes in lifestyle, diet, and environmental factors. This is leading to a larger patient pool and a growing demand for effective treatments. With the increased awareness of primary hyperoxaluria among patients and healthcare professionals, there is a greater likelihood of early diagnosis and treatment. This can lead to improved patient outcomes and an increased demand for treatment options. China has made significant progress in medical research and development, including the development of new therapies and treatment options for primary hyperoxaluria. This is likely to drive growth in the market as new and effective treatments become available. As China's economy continues to grow, there is an increasing focus on healthcare spending and improving access to healthcare services. This is likely to benefit the primary hyperoxaluria market, as patients seek more advanced and effective treatments. The Chinese government has implemented several policies to support the development of the healthcare industry, including policies that encourage investment in research and development. This is likely to benefit the primary hyperoxaluria market, as it encourages the development of new treatments and therapies.

Market Restraints

Despite increasing awareness of primary hyperoxaluria in China, there is still a lack of understanding of the disease among the general population and healthcare professionals. This can lead to delayed diagnosis and treatment, which can worsen patient outcomes. Currently, there are limited treatment options available for primary hyperoxaluria, and many of them are not widely available in China. This can limit patient access to effective treatments and hinder market growth. The cost of treatment for primary hyperoxaluria can be high, which can limit patient access and impact market growth. This is especially true for newer and more advanced treatments, which can be more expensive.

Competitive Landscape

Key Players

  • Arbor Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Dicerna Pharmaceuticals
  • OxThera
  • Retrophin Pharma
  • Pharming Group

Healthcare Policies and Regulatory Landscape

The healthcare policy and regulatory framework in China for the primary hyperoxaluria market is complex and evolving. China's drug approval process is regulated by the National Medical Products Administration (NMPA), which is responsible for reviewing and approving new drug applications. The process can be lengthy and requires extensive clinical trials and data to demonstrate safety and efficacy.

China has implemented significant healthcare reforms in recent years, including expanding access to healthcare services and increasing funding for research and development. These reforms are expected to benefit the primary hyperoxaluria market by improving patient access to treatments and encouraging investment in research and development.

Pricing and reimbursement of healthcare products in China is regulated by the National Healthcare Security Administration (NHSA). Companies seeking to enter the primary hyperoxaluria market must navigate the complex pricing and reimbursement system to ensure that their products are accessible to patients.

Reimbursement Scenario

Reimbursement for healthcare products in China is regulated by the National Healthcare Security Administration (NHSA). The reimbursement scenario for primary hyperoxaluria treatments in China can be complex and challenging.  Primary hyperoxaluria treatments are typically classified as "specialized drugs" in China, which means they are subject to a separate reimbursement process. The NHSA sets reimbursement rates for healthcare products in China, and the rates can vary depending on several factors, including the type of product, the severity of the disease, and the patient population. Reimbursement rates for primary hyperoxaluria treatments in China can be relatively low, which can limit patient access and impact market growth. In some cases, companies may be able to negotiate with the NHSA to increase the reimbursement rates for their products. However, this can be a challenging and time-consuming process, and success is not guaranteed.

 

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Primary Hyperoxaluria (PH) Therapeutics Market Segmentation

By Diagnostic method

  • Blood tests & Urine tests
  • Stone analysis
  • X-ray Examination
  • CT scanning & MRI
  • Biopsy
  • Molecular genetic testing
  • DNA Testing

By Treatment

  • Dietary
  • Lifestyle
  • Drug
  • Kidney Stone Management
  • Dialysis
  • Kidney/liver transplant

By Type

  • Primary Hyperoxaluria Type I
  • Primary Hyperoxaluria Type II
  • Primary Hyperoxaluria Type III

 

 

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 20 June 2023
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up